Drug Resistance

HIV Resistance Testing Contract Awarded

Published in AIDS Weekly, August 28th, 2000

The U.S. Centers for Disease Control and Prevention (CDC) has awarded a contract to Virco, Baltimore, Maryland, to conduct the testing for the agency's pivotal survey of transmission of drug-resistant strains of HIV in the U.S.

The most important criterion for awarding this type of contract is technical quality, followed by reasonable pricing. The contract includes VircoGEN II tests, Virco's genotypic resistance test that identifies mutations in the genetic code of HIV that cause drug resistance, and Antivirogram phenotypic tests, which measure the ability of the virus to grown in the presence of each of the drugs in the laboratory.

Historically, a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2000-08-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry